Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer
Open Access
- 29 November 2019
- journal article
- letter
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 4 (1), 1-3
- https://doi.org/10.1038/s41392-019-0088-z
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81472799, 81472799, 81472799, 81472799, 81472799)
This publication has 7 references indexed in Scilit:
- KRAS: Reasons for optimism in lung cancerEuropean Journal of Cancer, 2018
- Inflammatory genes are novel prognostic biomarkers for colorectal cancerInternational Journal of Molecular Medicine, 2018
- Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppressionSeminars in Cancer Biology, 2018
- Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancerBritish Journal of Cancer, 2017
- A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and MetastasisCell, 2014
- Introducing a Novel and Robust Technique for Determining Lymph Node Status in Colorectal CancerAnnals of Surgery, 2014
- CDK4 coexpression with Ras generates malignant human epidermal tumorigenesisNature Medicine, 2002